Htlv-1 associated myelopathy Clinical Trials
Conditions / Htlv-1 associated myelopathy
Delta Trials records 2 clinical trials for Htlv-1 associated myelopathy in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 15 study locations around the world. An additional 2 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
2
Total Trials
0
Recruiting
0
Completed
2
Other Active
1
Terminated since 2020
15
Study Locations
Browse by location (15 total)
- Kyoto, Japan 1 trialAll trials in Kyoto, Japan
- Ginowan, Japan 1 trialAll trials in Ginowan, Japan
- Kagoshima, Japan 1 trialAll trials in Kagoshima, Japan
- Tone, Japan 1 trialAll trials in Tone, Japan
- Nagoya, Japan 1 trialAll trials in Nagoya, Japan
- Sendai, Japan 1 trialAll trials in Sendai, Japan
- Kawasaki, Japan 1 trialAll trials in Kawasaki, Japan
- Kumamoto, Japan 1 trialAll trials in Kumamoto, Japan
- Kitakyushu, Japan 1 trialAll trials in Kitakyushu, Japan
- Hirakata, Japan 1 trialAll trials in Hirakata, Japan
- Fukuoka, Japan 1 trialAll trials in Fukuoka, Japan
- Ōita, Japan 1 trialAll trials in Ōita, Japan
- Miyakonojō, Japan 1 trialAll trials in Miyakonojō, Japan
- Fuzhou, China 1 trialAll trials in Fuzhou, China
- Nakagami, Japan 1 trialAll trials in Nakagami, Japan